Tabak, F. Et Al. 2018. Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey. International Liver Congress (ILC) , (Paris, France).

Tabak, F., Cuvalci, N. O., Kurtaran, B., Onlen, Y., Sari, N. D., Kaya, S., ... Ince, N.(2018). Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey . International Liver Congress (ILC), Paris, France

Tabak, F. Et Al. "Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey," International Liver Congress (ILC), Paris, France, 2018

Tabak, F. Et Al. "Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey." International Liver Congress (ILC) , Paris, France, 2018

Tabak, F. Et Al. (2018) . "Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey." International Liver Congress (ILC) , Paris, France.

@conferencepaper{conferencepaper, author={F. Tabak Et Al. }, title={Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey}, congress name={International Liver Congress (ILC)}, city={Paris}, country={France}, year={2018}}